Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Padsevonil in Adult and Elderly Participants
NCT04013191Phase 1Completed
- Sponsor
- UCB
- Start
- Jul 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of padsevonil in focal epilepsy and epilepsy (2 arms), sponsored by UCB. Primary endpoints: Maximum Plasma Concentration of a Single Dose Padsevonil, Area Under the Curve From 0 to t of a Single Dose Padsevonil and 3 more. Started Jul 2019; status: completed.
02
Drugs
padsevonil
03
Conditions
focal epilepsyepilepsy
Beyond the preview
Go deeper on NCT04013191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04013191.